OLIGOPROGRESSION
Clinical trials for OLIGOPROGRESSION explained in plain language.
Never miss a new study
Get alerted when new OLIGOPROGRESSION trials appear
Sign up with your email to follow new studies for OLIGOPROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain radiation face-off: which dose schedule wins for tumor control and fewer side effects?
Disease control Recruiting nowThis study compares two ways of delivering high-dose radiation to people with up to 5 brain metastases from solid tumors. One method gives a single large dose, while the other splits the dose into three smaller sessions. The goal is to see which approach better controls tumor gro…
Matched conditions: OLIGOPROGRESSION
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated May 17, 2026 01:51 UTC
-
Precision radiation may delay next chemotherapy in spreading cancers
Disease control Recruiting nowThis study tests whether a precise, high-dose radiation treatment (SABR) works better than standard palliative radiation for people with cancer that has spread to a few spots and is starting to grow again. About 194 adults with solid tumors (not lymphoma or myeloma) and up to 5 g…
Matched conditions: OLIGOPROGRESSION
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
One shot or several? new study tests best radiation dose for spreading cancer
Symptom relief Recruiting nowThis study compares giving a single high-dose radiation treatment versus several smaller doses for people whose cancer has spread to a few places (up to 5 spots). The goal is to see which approach causes fewer side effects, better controls the cancer, and improves quality of life…
Matched conditions: OLIGOPROGRESSION
Phase: NA • Sponsor: Robert Olson • Aim: Symptom relief
Last updated May 11, 2026 20:54 UTC